Loading...

BioNTech SE

BNTXNASDAQ
HealthcareBiotechnology
$113.10
$17.29(18.05%)

BioNTech SE BNTX Peers

See (BNTX) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BNTX$113.10+18.05%27.2B-31.59-$3.58N/A
VRTX$445.43+0.76%114.4B-117.22-$3.80N/A
REGN$490.81+0.11%52.1B12.48$39.32+0.36%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$306.16+0.53%39.9B-145.79-$2.10N/A
ARGX$584.72+2.00%35.7B35.70$16.38N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
RPRX$33.26+1.16%18.7B13.58$2.45+2.60%
UTHR$325.48+2.08%14.7B12.97$25.09N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BNTX vs VRTX Comparison

BNTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BNTX stands at 27.2B. In comparison, VRTX has a market cap of 114.4B. Regarding current trading prices, BNTX is priced at $113.10, while VRTX trades at $445.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BNTX currently has a P/E ratio of -31.59, whereas VRTX's P/E ratio is -117.22. In terms of profitability, BNTX's ROE is -0.04%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, BNTX is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for BNTX.

Stock Price Comparison

Loading...

Frequently Asked Questions